| Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti–PD-1 treatment E Peranzoni, J Lemoine, L Vimeux, V Feuillet, S Barrin, C Kantari-Mimoun, ... Proceedings of the National Academy of Sciences 115 (17), E4041-E4050, 2018 | 828 | 2018 |
| Preclinical murine tumor models: a structural and functional perspective MV Guerin, V Finisguerra, BJ Van den Eynde, N Bercovici, A Trautmann Elife 9, e50740, 2020 | 123 | 2020 |
| The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression JM Weiss, MV Guérin, F Regnier, G Renault, I Galy-Fauroux, L Vimeux, ... Oncoimmunology 6 (10), e1346765, 2017 | 107 | 2017 |
| The remarkable plasticity of macrophages: a chance to fight cancer N Bercovici, MV Guérin, A Trautmann, E Donnadieu Frontiers in immunology 10, 1563, 2019 | 96 | 2019 |
| Tumor-intrinsic sensitivity to the pro-apoptotic effects of IFN-γ is a major determinant of CD4+ CAR T-cell antitumor activity M Boulch, M Cazaux, A Cuffel, MV Guerin, Z Garcia, R Alonso, F Lemaître, ... Nature Cancer 4 (7), 968-983, 2023 | 60 | 2023 |
| TGFβ blocks IFNα/β release and tumor rejection in spontaneous mammary tumors MV Guerin, F Regnier, V Feuillet, L Vimeux, JM Weiss, G Bismuth, ... Nature communications 10 (1), 4131, 2019 | 48 | 2019 |
| Dynamic CD8+ T Cell Cooperation with Macrophages and Monocytes for Successful Cancer Immunotherapy A Vermare, MV Guérin, E Peranzoni, N Bercovici Cancers 14 (14), 3546, 2022 | 20 | 2022 |
| Anti-PD-1 therapy triggers Tfh cell–dependent IL-4 release to boost CD8 T cell responses in tumor-draining lymph nodes M Ruggiu, MV Guérin, B Corre, M Bardou, R Alonso, E Russo, Z Garcia, ... Journal of Experimental Medicine 221 (4), e20232104, 2024 | 8 | 2024 |
| Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse M v Guerin, F Regnier, M Thoreau, L Vimeux, M Benard, E Dransart, ... Journal for Immunotherapy of Cancer 8 (2), 2020 | 1 | 2020 |
| TGFβ blocks STING-induced IFNα/β release and tumor rejection in spontaneous mammary tumors MV Guerin, F Regnier, V Feuillet, L Vimeux, JM Weiss, T Guilbert, ... BioRxiv, 336990, 2018 | 1 | 2018 |
| Immunothérapie des cancers par anticorps anti-PD-1-Le rôle inattendu de l’interleukine 4 dans le ganglion lymphatique drainant la tumeur MV Guérin, M Ruggiu, P Bousso médecine/sciences 40 (8-9), 613-615, 2024 | | 2024 |
| The unexpected role of interleukin 4 within the draining lymph node in response to anti-PD1 therapy MV Guérin, M Ruggiu, P Bousso Medecine sciences: M/S 40 (8-9), 613-615, 2024 | | 2024 |
| P09. 07 Deciphering the nature of the cooperation between monocytes/macrophages and CD8+ T cells during immunotherapy-induced tumor regression A Vermare, A Rouault, A Ventura, B Saint-Pierre, W Zeitouni, K Mulder, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 1), 2022 | | 2022 |
| L1 TGF-beta blocks type I IFN release and tumor rejection in spontaneous mammary tumors N Bercovici, MV Guérin, F Regnier, JM Weiss, V Feuillet, L Vimeux, ... Journal for ImmunoTherapy of Cancer 8 (Suppl 2), 2020 | | 2020 |
| Dynamique des interactions entre cellules immunes lors de régressions tumorales M Guérin Université Paris Cité, 2020 | | 2020 |
| TGFbeta Blocks IFNalpha/beta Release and Tumor Rejection in Spontaneous Mammary Tumors: TGFβ Blocks IFNα/β Release and Tumor Rejection in Spontaneous Mammary Tumors MV Guerin, F Regnier, V Feuillet, L Vimeux, JM Weiss, G Bismuth, ... Universität, 2019 | | 2019 |
| Abstract A05: Biphasic anti-tumoral effect of a vascular-disrupting agent triggering STING and tumor regression JM Weiss, M Guerin, F Regnier, M Thoreau, E Peranzoni, V Feuillet, ... Cancer Immunology Research 5 (3_Supplement), A05-A05, 2017 | | 2017 |
| Abstracts from the 4th ImmunoTherapy of Cancer Conference: Prague, Czech Republic. 20–22 March 2017 J Ženka, V Caisová, O Uher, P Nedbalová, K Kvardová, K Masáková, ... Journal for ImmunoTherapy of Cancer 5, 1-19, 2017 | | 2017 |
